Results 231 to 240 of about 410,939 (360)
Targeted protein degradation in oncology: novel therapeutic opportunity for solid tumours?
Current anticancer therapies are limited by the occurrence of resistance and undruggability of most proteins. Targeted protein degraders are novel, promising agents that trigger the selective degradation of previously undruggable proteins through the recruitment of the ubiquitin–proteasome machinery. Their mechanism of action raises exciting challenges,
Noé Herbel, Sophie Postel‐Vinay
wiley +1 more source
Robust self supervised symmetric nonnegative matrix factorization to the graph clustering. [PDF]
Ru Y, Gruninger M, Dou Y.
europepmc +1 more source
Corrigendum: “Some factorizations of 2ⁿ±1 and related results” [PDF]
John Brillhart, J. L. Selfridge
openalex +1 more source
Projected Gradient Methods for Nonnegative Matrix Factorization
Chih-Jen Lin
semanticscholar +1 more source
Nuclear prothymosin α inhibits epithelial‐mesenchymal transition (EMT) in lung cancer by increasing Smad7 acetylation and competing with Smad2 for binding to SNAI1, TWIST1, and ZEB1 promoters. In early‐stage cancer, ProT suppresses TGF‐β‐induced EMT, while its loss in the nucleus in late‐stage cancer leads to enhanced EMT and poor prognosis.
Liyun Chen+12 more
wiley +1 more source
Retraction notice to "Non-negative matrix factorization model-based construction for molecular clustering and prognostic assessment of head and neck squamous carcinoma" [Heliyon 8 (2022) e10100]. [PDF]
Li XY+5 more
europepmc +1 more source
Infinite Primes and Unique Factorization in a Principal Right Ideal Domain [PDF]
Raymond A. Beauregard
openalex +1 more source
Does Porphyromonas gingivalis truly inhibit the oral carcinogenesis?
Chen‐xi Li, Zhong‐cheng Gong
wiley +1 more source
Neighbor-Enhanced Link Prediction in Bipartite Networks. [PDF]
Cheng G+5 more
europepmc +1 more source